CAR-T therapies & T-Cell Engagers represent two different approaches for directing T-cell-mediated killing of malignant cancer cells. Are they ready to tackle solid tumors?
Positron emission tomography (PET) has become widely used for cardiac disease and several cancers. New sensitive antigen-specific tracers are further extending PET usefulness in other settings, including prostate cancer and Alzheimer’s disease (AD).